UNITED
STATES DISTRICT COURT
FOR THE SOUTHERN DISTRICT OF FLORIDA
Northern
Division
| FEDERAL TRADE COMMISSION,
Plaintiff,
v.
MAJORS MEDICAL SUPPLY,
INC.,
a Florida Corporation,
STUART PHILLIPS,
individually and as an officer and
principal of Majors Medical Supply, Inc.
and
JOANNE PHILLIPS,
individually and as an officer and principal
of Majors Medical Supply, Inc.,
Defendants.
|
|
Civ.
Case No. Magistrate
COMPLAINT FOR PERMANENT
INJUNCTION, CONSUMER REDRESS, RESCISSION OF
CONTRACTS, AND OTHER EQUITABLE RELIEF.
|
Plaintiff, the Federal Trade
Commission, ("FTC" or "the
Commission"), for its complaint, alleges:
- The Commission brings this action
under Sections 13(b) and 19 of the Federal Trade
Commission Act ("FTC Act), 15 U.S.C. §§
53(b) and 57b, to secure a permanent injunction,
preliminary injunctive relief, rescission or
reformation of contracts, disgorgement,
appointment of a receiver, and other equitable
relief for defendants' deceptive acts or
practices in violation of Section 5(a) of the FTC
Act, 15 U.S.C. § 45(a), and the FTC's Trade
Regulation Rule entitled "Disclosure
Requirements and Prohibitions Concerning
Franchising and Business Opportunity Ventures
(the "Franchise Rule" or "the
Rule"), 16 C.F.R. Part 436.
JURISDICTION
AND VENUE
- This Court has jurisdiction over
this matter pursuant to 28 U.S.C. §§ 1331,
1337(a) and 1345, and 15 U.S.C. §§ 53(b) and
57b.
- Venue in the Southern District of
Florida is proper under 28 U.S.C. §§ 1391(b)
and (c), and 15 U.S.C. § 53(b).
PLAINTIFF
- Plaintiff, the Federal Trade
Commission, is an independent agency of the
United States Government created by statute. 15
U.S.C. §§ 41 et seq. The
Commission is charged, inter alia,
with enforcement of Section 5(a) of the FTC Act,
15 U.S.C. § 45(a), which prohibits unfair
or deceptive acts or practices in or affecting
commerce, as well as enforcement of the Franchise
Rule, 16 C.F.R. Part 436. The Commission is
authorized to initiate federal district court
proceedings to enjoin violations of the FTC Act,
to secure such equitable relief as may be
appropriate in each case, and to obtain consumer
redress. 15 U.S.C. §§ 53(b) and 57b.
DEFENDANTS
- Defendant Stuart Phillips is a
founder of defendant Majors Medical Supply, Inc.
("MMS"). He is currently the
vice-president and has been a principal of the
company since its inception. He resides at 5757
NW 40th Way, Boca Raton, Florida, and his
principal place of business is at 2600 N.
Military Trail, Suite 390, Boca Raton, Florida
33431. At all times material to this complaint,
acting alone or in concert with others, he has
formulated, directed, controlled or participated
in the acts and practices of the corporate
defendant, including the acts and practices set
forth in this complaint.
- Defendant Joanne Phillips, who is
married to Stuart Phillips, is the co-founder of
MMS. She owns MMS and is its president. She has
been a principal in the company since its
inception. She resides at 5757 NW 40th Way, Boca
Raton, Florida, and her principal place of
business is at 2600 N. Military Trail, Suite 390,
Boca Raton, Florida 33431. At all times material
to this complaint, acting alone or in concert
with others, she has formulated, directed,
controlled or participated in the acts and
practices of the corporate defendant, including
the acts and practices set forth in this
complaint.
- Defendant Majors Medical Supply,
Inc., a Florida corporation with its principal
place of business at 2600 N. Military Trail,
Suite 390, Boca Raton, Florida 33431, promotes,
offers to sell, and sells home medical equipment
franchises. At all times material to this
complaint, MMS has transacted business in the
Southern District of Florida.
COMMERCE
- At all times relevant to this
complaint, the defendants have maintained a
substantial course of trade or business in the
offering for sale and sale of home medical
equipment franchises, in or affecting commerce,
as "commerce" is defined in Section 4
of the FTC Act, 15 U.S.C. § 44.
DEFENDANTS'
COURSE OF BUSINESS
- Since at least 1995, the
defendants have promoted, offered for sale, and
sold home medical equipment franchises
nationwide. MMS franchisees sell or rent medical
equipment to consumers and are reimbursed by
Medicare, Medicaid, or other insurance carriers.
The defendants sell exclusive territories for
between $25,000 and $35,000. MMS promises to
provide substantial assistance to its franchisees
including: training the franchisees in how to
sell home medical equipment; incorporating the
franchisees' companies; placing the franchisees'
orders for medical equipment with vendors;
billing the insurance carriers on behalf of the
franchisees; obtaining Medicare Supplier Numbers
for its franchisees; developing advertising and
advertising strategies for the franchisees;
updating its franchisees on changes in Medicare
and Medicaid requirements; and providing a staff
to assist franchisees in any questions they have
once they have started their business. The
defendants induce individuals to purchase their
franchises through representations about the cost
of opening a franchise and the earnings potential
of its franchises.
VIOLATIONS OF
SECTION 5 OF THE FTC ACT
- Section 5(a) of the FTC Act, 15
U.S.C. § 45(a), prohibits "unfair or
deceptive acts or practices in or affecting
commerce."
COUNT I
- Paragraphs 1 through 10 are
incorporated herein by reference.
- In numerous instances, in the
course of promoting, offering for sale and
selling home medical equipment franchises,
defendants have represented, directly or by
implication, that an initial investment of
$39,110 was sufficient to join MMS and open and
operate an office for three months. Later,
defendants represented that franchisees would
need $47,225 to open and operate an MMS office
for three months.
- In truth and fact, in numerous
instances, the amounts stated by defendants have
not been sufficient to join MMS and open and
operate an office for three months. Many
franchisees have had to spend thousands of
dollars over and above the figures represented by
the defendants.
- Therefore, the defendants'
representations regarding the initial investment
required to join MMS and open an office and
operate for three months, as set forth in
Paragraph 12, were and are false and misleading,
and constitute deceptive acts or practices in
violation of Section 5(a) of the FTC Act, 15
U.S.C. § 45(a)
COUNT II
- Paragraphs 1 through 14 are
incorporated herein by reference.
- In numerous instances, in the
course of promoting, offering for sale, and
selling home medical equipment franchises,
defendants have represented, directly or by
implication, that purchasers would achieve
profits of at least $10,466 or $13,295 after
three months of operation.
- In truth and fact, in numerous
instances purchasers have not achieved the
profits claimed by the defendants after three
months of operation.
- Therefore, the defendants'
representations regarding profit levels, as set
forth in Paragraph 16, were and are false and
misleading, and constitute deceptive acts or
practices in violation of Section 5(a) of the FTC
Act, 15 U.S.C. § 45(a).
THE FRANCHISE
RULE
- The home medical equipment
businesses sold by the defendants are franchises,
as "franchise" is defined in Section
436.2(a) of the Franchise Rule, 16 C.F.R. §
436.2(a).
- The Franchise Rule requires a
franchisor to provide prospective franchisees
with a complete and accurate basic disclosure
statement containing twenty categories of
information, including information about the
history of the franchisor, the terms and
conditions under which the franchise operates,
and information about other franchisees
("disclosure document"). 16 C.F.R. §§
436.1(a)(1)-(20). Disclosure of this information
enables a prospective franchisee to assess the
potential risks involved in the franchise.
- The Franchise Rule also requires
that the franchisor provide prospective
franchisees with a document containing
information substantiating any oral, written, or
visual earnings or profit representations that
the franchisor makes to prospective franchisees,
16 C.F.R. § 436.1(b)-(e).
- The Franchise Rule also requires
franchisors to provide purchasers with the
disclosure document and the earnings document at
the earlier of either the first face-to-face
meeting or ten business days prior to the
execution by the franchisee of a franchise
agreement or the payment by the prospective
franchisee of any consideration in connection
with the sale or proposed sale of a franchise. 16
C.F.R. § 436.1(a).
- Pursuant to Section 18(d)(3) of
the FTC Act, 15 U.S.C. § 57a(d)(3), and 16
C.F.R. § 436.1, violations of the Franchise
Rule constitute unfair or deceptive acts or
practices in or affecting commerce, in violation
of Section 5(a) of the FTC Act, 15 U.S.C.
§ 45(a).
VIOLATIONS OF
THE FRANCHISE RULE
COUNT III
- Paragraphs 1 through 23 are
incorporated herein by reference.
- In numerous instances in
connection with promoting, offering for sale and
selling franchises, as "franchise" is
defined in the Rule, 16 C.F.R. § 436.2(a), the
defendants have failed to provide prospective
franchisees with a disclosure document in the
manner and within the time frame required by the
Franchise Rule, thereby violating Section
436.1(a) of the Rule, 16 C.F.R. §
436.1(a)(1)-(20), and Section 5(a) of the FTC
Act, 15 U.S.C. § 45(a).
COUNT IV
- Paragraphs 1 through 25 are
incorporated herein by reference.
- In numerous instances in
connection with promoting, offering for sale and
selling franchises, as "franchise" is
defined in the Rule, 16 C.F.R. § 436.2(a), the
defendants have made earnings claims, within the
meaning of Section 436.1(b)-(d) of the Franchise
Rule, 16 C.F.R. § 436.1(b)-(d), but have failed
to provide prospective franchisees the earnings
claims document required by the Franchise Rule in
the manner and within the time frame required by
the Rule, thereby violating Section 436.1(b)-(d)
of the Franchise Rule, 16 C.F.R. § 436.1(b)-(d),
and Section 5(a) of the FTC Act, 15 U.S.C. §
45(a).
CONSUMER
INJURY
- Consumers in many areas of the
United States have suffered and continue to
suffer substantial monetary loss as a result of
defendants' unlawful acts or practices in their
ongoing sales of franchises. Absent injunctive
relief by this Court, defendants are likely to
continue to injure consumers.
THIS COURT'S
POWER TO GRANT RELIEF
- Section 13(b) of the FTC Act, 15
U.S.C. § 53(b), authorizes this Court to grant
injunctive and other equitable relief, including
the rescission of contracts, restitution, and
disgorgement to prevent and remedy any violations
of any provision of law enforced by the Federal
Trade Commission.
- Section 19 of the FTC Act, 15
U.S.C. § 57b, authorizes this Court to grant
such relief as the Court finds necessary to
redress injury to consumers or other persons
resulting from defendants' violations of the
Franchise Rule, including rescission of
contracts, restitution, and disgorgement.
PRAYER FOR
RELIEF
WHEREFORE, the plaintiff, the Federal
Trade Commission, requests that this Court, as authorized
by Sections 13(b) and 19 of the FTC Act, 15 U.S.C. §§
53(b) and 57b, and pursuant to its own equitable powers:
- 1. Award plaintiff such
preliminary injunctive and ancillary relief as
may be necessary to avert the likelihood of
consumer injury during the pendency of this
action and to preserve the possibility of
effective final relief, including but not limited
to, temporary and preliminary injunctions,
appointment of a receiver, and an order freezing
each defendants' assets;
-
- 2. Permanently enjoin the
defendants from violating the FTC Act and the
Franchise Rule, as alleged herein;
-
- 3. Award such relief as the Court
finds necessary to redress injury to consumers
resulting from the defendants' violations of the
FTC Act and the Franchise Rule including, but not
limited to, rescission of contracts, the refund
of monies paid, and the disgorgement of
ill-gotten monies; and
-
- 4. Award plaintiff the costs of
bringing this action, as well as such other and
additional relief as the Court may determine to
be just and proper.
Respectfully Submitted,
STEPHEN CALKINS
General Counsel
Allen M. Hile
Assistant Director
Division of Marketing Practices
Collot Guerard
Attorney for Plaintiff
Federal Trade Commission
Room 238
600 Pennsylvania Avenue, N.W.
Washington, D.C. 20580
(202) 326-3338 (o)
(202) 326-3395 (fax)
|